Farrukh T Shah

发表

A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload.

Vip Viprakasit, Hugh Young Rienhoff, Paul Harmatz, 2012, Blood.

Iron overload in thalassemia and related conditions: therapeutic goals and assessment of response to chelation therapies.

Farrukh T Shah, John B Porter, J. Porter, 2010, Hematology/oncology clinics of North America.

Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload

S. K. White, M. Robson, P. Kellman, 2015, Journal of magnetic resonance imaging : JMRI.

Effectiveness and Safety of Sitagliptin in Patients with Beta-thalassaemia Major and Diabetes Mellitus: A Case Series

Farrukh T Shah, S. Zonoozi, Ploutarchos Tzoulis, 2016, Mediterranean journal of hematology and infectious diseases.

On myocardial siderosis and left ventricular dysfunction in hemochromatosis

D. Pennell, J. Carpenter, Farrukh T Shah, 2013, Journal of Cardiovascular Magnetic Resonance.

National comparative audit of blood transfusion: 2014 audit of transfusion services and practice in children and adults with sickle cell disease

L. Estcourt, D. Lowe, P. Bolton-Maggs, 2019, Transfusion medicine.

Promoting Adherence to Iron Chelation Treatment in Beta-Thalassemia Patients

Farrukh T Shah, K. Anie, C. Eziefula, 2022, Patient preference and adherence.

History of myocardial iron loading is a strong risk factor for diabetes mellitus and hypogonadism in adults with β thalassemia major

Farrukh T Shah, Ai Leen Ang, B. Davis, 2014, European journal of haematology.

A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.

E. Neufeld, S. Perrotta, M. Cappellini, 2020, The New England journal of medicine.

Challenges of blood transfusions in β-thalassemia.

A. Piga, Farrukh T Shah, F. Sayani, 2019, Blood reviews.

Prospective study of histomorphometry, biochemical bone markers and bone densitometric response to pamidronate in β‐thalassaemia presenting with osteopenia‐osteoporosis syndrome

Farrukh T Shah, R. Bajoria, R. Chatterjee, 2012, British journal of haematology.

Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias

B. Kaya, S. Pancham, Farrukh T Shah, 2021, British journal of haematology.

Adherence to treatment: Doctor vs patient perspective

Farrukh T Shah, G. Kaltsounis, 2018 .

Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID‐19 pandemic

S. Lugthart, J. Howard, Farrukh T Shah, 2020, British journal of haematology.

The Believe Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept in Adult Beta-Thalassemia Patients Who Require Regular Red Blood Cell (RBC) Transfusions

E. Neufeld, S. Perrotta, M. Cappellini, 2018, Blood.

Routine management, healthcare resource use and patient and carer‐reported outcomes of patients with transfusion‐dependent β‐thalassaemia in the United Kingdom: A mixed methods observational study

S. Pancham, Farrukh T Shah, P. Telfer, 2019, EJHaem.

Addressing Adherence to Treatment: A Longstanding Concern. The Health Care Professional

Farrukh T Shah, 2014, Thalassemia Reports.

A Decade Follow-up of a Thalassemia Major (TM) Cohort Monitored by Cardiac Magnetic Resonance Imaging (CMR): Significant Reduction In Patients with Cardiac Iron and In Total Mortality

D. Pennell, J. Moon, J. M. Walker, 2010 .

FBS0701, a novel oral iron chelator, in transfusional iron overload A phase 2 study of the safety, tolerability and pharmacodynamics of

E. Neufeld, V. Viprakasit, R. Galanello, 2012 .

Joint Diabetes Thalassaemia Clinic: An Effective New Model of Care

Farrukh T Shah, Ploutarchos Tzoulis, M. Barnard, 2014, Hemoglobin.

Adults with Severe Sickle Cell Anaemia and Iron Overload Have a High Incidence of Osteopenia and Osteoporosis.

Farrukh T Shah, R. Chatterjee, J. Porter, 2004 .

Health state utilities for beta-thalassemia: a time trade-off study

A. Martin, Farrukh T Shah, M. Oppe, 2022, The European Journal of Health Economics.

The prevalence of hepatitis C virus (HCV) infection in Î²-thalassemia patients in Pakistan: a systematic review and meta-analysis

S. Akhtar, Farrukh T Shah, A. Hinde, 2019, medRxiv.

Prevalence of Low Bone Mass and Vitamin D Deficiency in β-Thalassemia Major

Farrukh T Shah, M. Berovic, Ai Leen Ang, 2014, Hemoglobin.

Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patients

F. Piel, S. Lugthart, R. Hollingsworth, 2020, Haematologica.

Safety and Efficacy of Peginterferon Alfa-2a and Ribavirin for Hepatitis C in Thalassemia.

E. Vichinsky, M. Jonas, N. Olivieri, 2006 .

Early Hepatitis C Viral Response (EVR) to Peginterferon Alfa 2a and Ribavirin in Patients with β Thalassemia.

E. Vichinsky, N. Olivieri, P. Harmatz, 2004 .

Right ventricular volumes and function in thalassemia major patients in the absence of myocardial iron overload

D. Pennell, W. Banya, T. He, 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

Normalized left ventricular volumes and function in thalassemia major patients with normal myocardial iron

D. Pennell, L. Anderson, M. Westwood, 2007, Journal of magnetic resonance imaging : JMRI.

Safety, Tolerability and Dose Response of FBS0701, a Novel Iron Chelator for Treatment of Transfusional Iron Overload: Results of a 24-Week Multicenter, International Phase 2 Study

E. Neufeld, H. Rienhoff, E. Vichinsky, 2011 .

Myocardial tissue characterization and the role of chronic anemia in sickle cell cardiomyopathy

D. Pennell, L. Anderson, M. Tanner, 2007, Journal of magnetic resonance imaging : JMRI.

Health-Related Quality of Life Outcomes for Patients with Transfusion-Dependent Beta-Thalassemia Treated with Luspatercept in the Believe Trial

E. Neufeld, M. Cappellini, V. Viprakasit, 2020 .

Deferiprone Is Associated with Lower Serum Ferritin (SF) Relative to Liver Iron Concentration (LIC) Than Deferoxamine and Deferasirox- Implications for Clinical Practice

Farrukh T Shah, J. Porter, Ai Leen Ang, 2010 .

Virtual Learning Using Interactive Multimedia-Based Tools for Knowledge Transfer and Development of Global Patient Care Pathway in Haemoglobinopathies

Charles H Rodeck, Rekha Bajoria, Farrukh Shah, 2011, Hemoglobin.

Psychological Factors Associated with Episodic Chelation Adherence in Thalassemia

Jane Vosper, Farrukh T Shah, J. Porter, 2018, Hemoglobin.

High index of suspicion for early diagnosis of alendronate‐induced stage zero osteonecrosis of jaw in thalassaemia major

S. Fedele, Farrukh T Shah, R. Bajoria, 2014, British journal of haematology.

Health‐related quality of life in patients with β‐thalassemia: Data from the phase 3 BELIEVE trial of luspatercept

E. Neufeld, M. Cappellini, V. Viprakasit, 2023, European journal of haematology.

Iron overload in thalassemia and related conditions: therapeutic goals and assessment of response to chelation therapies.

Farrukh T Shah, J. Porter, 2010, Hematology/oncology clinics of North America.